Cyclacel Pharmaceuticals Statistics
Total Valuation
CYCC has a market cap or net worth of $7.37 million. The enterprise value is $3.93 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CYCC has 22.27 million shares outstanding. The number of shares has increased by 21,357.35% in one year.
| Current Share Class | 22.27M |
| Shares Outstanding | 22.27M |
| Shares Change (YoY) | +21,357.35% |
| Shares Change (QoQ) | +2,143.31% |
| Owned by Insiders (%) | 88.93% |
| Owned by Institutions (%) | 0.10% |
| Float | 747,346 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 526.58 |
| Forward PS | 96.37 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 2.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 280.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.60 |
| Quick Ratio | 5.20 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,950.23% and return on invested capital (ROIC) is -1,789.64%.
| Return on Equity (ROE) | -1,950.23% |
| Return on Assets (ROA) | -160.18% |
| Return on Invested Capital (ROIC) | -1,789.64% |
| Return on Capital Employed (ROCE) | -413.06% |
| Revenue Per Employee | $1,167 |
| Profits Per Employee | -$695,583 |
| Employee Count | 12 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CYCC has paid $572,000 in taxes.
| Income Tax | 572,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.88% in the last 52 weeks. The beta is 0.25, so CYCC's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -98.88% |
| 50-Day Moving Average | 2.20 |
| 200-Day Moving Average | 6.57 |
| Relative Strength Index (RSI) | 26.14 |
| Average Volume (20 Days) | 3,900,972 |
Short Selling Information
The latest short interest is 595,114, so 2.67% of the outstanding shares have been sold short.
| Short Interest | 595,114 |
| Short Previous Month | 31,977 |
| Short % of Shares Out | 2.67% |
| Short % of Float | 79.63% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, CYCC had revenue of $14,000 and -$8.35 million in losses. Loss per share was -$0.64.
| Revenue | 14,000 |
| Gross Profit | 14,000 |
| Operating Income | -12.69M |
| Pretax Income | -22.73M |
| Net Income | -8.35M |
| EBITDA | -12.68M |
| EBIT | -12.69M |
| Loss Per Share | -$0.64 |
Full Income StatementBalance Sheet
The company has $3.45 million in cash and $9,000 in debt, giving a net cash position of $3.44 million or $0.15 per share.
| Cash & Cash Equivalents | 3.45M |
| Total Debt | 9,000 |
| Net Cash | 3.44M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 3.06M |
| Book Value Per Share | 0.24 |
| Working Capital | 3.05M |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.75M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.75M |
| FCF Per Share | -$0.48 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -90,607.14% |
| Pretax Margin | -55,535.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CYCC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21,357.35% |
| Shareholder Yield | -21,357.35% |
| Earnings Yield | -113.22% |
| FCF Yield | -145.87% |
Dividend DetailsAnalyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 12, 2025. It was a reverse split with a ratio of 0.0625:1.
| Last Split Date | May 12, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0625:1 |
Scores
CYCC has an Altman Z-Score of -168.12 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -168.12 |
| Piotroski F-Score | 1 |